YpsoMate 2.25 and YpsoMate 2.25 Pro now also available for 8 mm needle

The YpsoMate 2.25 and YpsoMate 2.25 Pro configuration with an 8 mm needle enhances the trusted YpsoMate platform by providing greater versatility and improved patient comfort. It retains the familiar YpsoMate ergonomic design with push-on-skin activation, reducing development and regulatory risks while ensuring reliable performance. By offering reduced injection force and time, it accommodates a wide range of drug formulations for various therapy needs. 

Reusable autoinjector

Main benefits

  • The new configuration reduces injection time and effort, enhancing patient comfort and experience.
  • YpsoMate 2.25 and YpsoMate 2.25 Pro with a shorter needle and larger internal diameter, ensure fast delivery of high-viscosity drugs and expand treatment options.
  • YpsoMate proven platform, with its ergonomic design, minimizes development and regulatory risks, ensuring reliable performance.
  • Supporting our customer’s sustainability goals, YpsoMate 2.25 and YpsoMate 225 Pro with an 8 mm needle are available in the NetZero Program.
YpsoMate 2.25 mL 8 mm autoinjector device specifications showing dimensions and device details.

Dimensions and specifications

Facts and figures
  • Needle type8 mm needle
  • Primary container2.25 mL 8 mm PFS, with cut flange or small round flange
  • Fill volume0.4 – 2.25 mL
  • DosingFixed, complete content
  • Viscosity1 – 40 cP1 for YpsoMate 2.25 | 1 – 80 cP1 for YpsoMate 2.25 Pro2
  • Needle diameter29G TW and larger
  • Injection timeapprox. 5 – 15 s (Ask for testing of your configuration)
  • PFS needle shieldRigid
  • Needle insertion depth6 mm
  • End of injection feedbackVisual and auditory
  • Weight53 g incl. glass PFS for YpsoMate 2.25 | 70 g incl. glass PFS for YpsoMate 2.25 Pro
  • CustomisationDosing, colours, shape
  • SafetyShielded needle (before, during, and after use), front shoulder syringe support, roll-stop design, audible confirmation clicks and visual feedback
  • ConnectivityYes, with SmartPilot add-on
  • SustainabilityAvailable in NetZero Program

1 Feasibility testing with filled syringes recommended for new drugs. With a larger needle diameter viscosities above 100 cP are feasible.

2 Timeline for readiness of the YpsoMate 2.25 Pro to be assessed for individual cases.

Get in touch​

Do you want to learn more about the Ypsomed platform range with 8 mm needle?

Please add 7 and 5.